GSK - GlaxoSmithKline plc

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5108.63B
Enterprise Value 3107.85B
Trailing P/E 43.84
Forward P/E 113.94
PEG Ratio (5 yr expected) 14.14
Price/Sales (ttm)N/A
Price/Book (mrq)18.08
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.34
52-Week Change 37.42%
S&P500 52-Week Change 321.46%
52 Week High 348.25
52 Week Low 338.43
50-Day Moving Average 346.23
200-Day Moving Average 343.91

Share Statistics

Avg Vol (3 month) 32.99M
Avg Vol (10 day) 33.47M
Shares Outstanding 52.51B
Float 2.45B
% Held by Insiders 10.01%
% Held by Institutions 111.88%
Shares Short (Jan 30, 2020) 46.65M
Short Ratio (Jan 30, 2020) 42.88
Short % of Float (Jan 30, 2020) 4N/A
Short % of Shares Outstanding (Jan 30, 2020) 40.31%
Shares Short (prior month Dec 30, 2019) 47.27M

Dividends & Splits

Forward Annual Dividend Rate 42.4
Forward Annual Dividend Yield 45.51%
Trailing Annual Dividend Rate 31.06
Trailing Annual Dividend Yield 32.43%
5 Year Average Dividend Yield 45.33
Payout Ratio 486.01%
Dividend Date 3Apr 08, 2020
Ex-Dividend Date 4Feb 19, 2020
Last Split Factor 22:1
Last Split Date 3Nov 11, 1991

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 13.76%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)7.44%
Return on Equity (ttm)47.83%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)8.60%
Gross Profit (ttm)22.96B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.99
Quarterly Earnings Growth (yoy)6.90%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)166.19
Current Ratio (mrq)0.81
Book Value Per Share (mrq)2.41

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A